Passegue E, Richard J L, Boulla G, Gourdji D
Groupe de Biologie de la Cellule Neuroendocrine, CNRS URA 1115, Collège de France, Paris.
Mol Cell Endocrinol. 1995 Jan;107(1):29-40. doi: 10.1016/0303-7207(94)03417-r.
In mammosomatotropes GH3B6 cells, one of the primary responses to thyrotropin-releasing hormone (TRH) is the parallel induction of two proto-oncogenes, c-fos and jun B, which code for constituents of AP1 transcription factor. To better understand the mode of action of TRH and to look for possible functions of c-fos and jun B in these cells, we have investigated the role of different intracellular signals in the induction of each proto-oncogene on the one hand, and on prolactin (PRL) release and PRL gene expression on the other hand. Northern and dot-blot analyses revealed that the activation of protein kinase C (PKC)-, Ca(2+)- or adenylyl cyclase-dependent pathways acutely increased both c-fos and jun B transcripts. However, a gene specific responsiveness was revealed using phorbol 12-myristate 13-acetate (TPA) and several combined treatments. The simultaneous activation of PKC and Ca(2+)-dependent pathways resulted in synergistic stimulations of c-fos mRNA levels only. Consistently, ionomycin plus low doses of TPA solely reproduced the potent effect of TRH on c-fos transcripts. Data collected from TRH and TPA down-regulated cells indicated that TRH probably recruits TPA-dependent PKC isoforms for stimulating c-fos but not jun B transcripts. On the contrary, the TRH-induced stimulation of either proto-oncogene likely involves Ca(2+)-dependent mechanisms because calcium agonists and the peptide exert non-additive effects. Finally, the synergistic stimulations observed in response to TRH combined with forskolin, indicate that adenylyl cyclase-dependent mechanisms are interconnected with TRH-induced proto-oncogene expression. The overall study also reveals that among the agonists tested, the dihydropyridine Bay K 8644 and forskolin only were capable to induce a long-lasting stimulation of c-fos and jun B mRNA levels, concomitant to increased levels of PRL transcripts, as does TRH. Considering that AP1 is assumed to be involved in signal transmission from the cell surface to the nucleus, it might be thus proposed that a common stimulation of c-fos and jun B gene expression is possibly involved in the activation of the PRL gene. On the other hand, the systematic coincidence between acute PRL release and proto-oncogenes expression suggest a role for c-fos and jun B in the control of genes involved in the secretory process.
在促生长激素细胞系GH3B6细胞中,促甲状腺激素释放激素(TRH)的主要反应之一是同时诱导两个原癌基因c-fos和jun B,它们编码AP1转录因子的组成成分。为了更好地理解TRH的作用模式,并寻找c-fos和jun B在这些细胞中的可能功能,我们一方面研究了不同细胞内信号在诱导每个原癌基因中的作用,另一方面研究了它们对催乳素(PRL)释放和PRL基因表达的作用。Northern印迹和点杂交分析显示,蛋白激酶C(PKC)、Ca²⁺或腺苷酸环化酶依赖性途径的激活可使c-fos和jun B转录本急剧增加。然而,使用佛波醇12-肉豆蔻酸酯13-乙酸酯(TPA)和几种联合处理揭示了基因特异性反应性。PKC和Ca²⁺依赖性途径的同时激活仅导致c-fos mRNA水平的协同刺激。同样,离子霉素加低剂量TPA单独就能重现TRH对c-fos转录本的强效作用。从TRH和TPA下调的细胞收集的数据表明,TRH可能募集TPA依赖性PKC同工型来刺激c-fos而不是jun B转录本。相反,TRH诱导的任一原癌基因的刺激可能涉及Ca²⁺依赖性机制,因为钙激动剂和该肽发挥非累加效应。最后,TRH与福斯高林联合使用时观察到的协同刺激表明,腺苷酸环化酶依赖性机制与TRH诱导的原癌基因表达相互关联。整体研究还表明,在所测试的激动剂中,只有二氢吡啶Bay K 8644和福斯高林能够像TRH一样诱导c-fos和jun B mRNA水平的持久刺激,并伴随PRL转录本水平的增加。鉴于AP1被认为参与从细胞表面到细胞核的信号传递,因此可以推测,c-fos和jun B基因表达的共同刺激可能参与PRL基因的激活。另一方面,急性PRL释放与原癌基因表达之间的系统一致性表明c-fos和jun B在控制参与分泌过程的基因中起作用。